- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
April 23rd, 2007
The Council for Scientific and Industrial Research (CSIR), in collaboration with international partner Ayanda Biosystems based at the Science Park of the Swiss Federal Institute of Technology in Lausanne is currently developing nanotechnology capsules for tuberculosis (TB) treatment.
Known as 'the technology of the very small', nanotechnology enables scientists to manipulate materials and particles that are a billionth of a metre, or about 1/80 000th of the diameter of a human hair.
The nanocapsules were being tested on animals, and the developers hoped that they would eventually decrease the number and frequency of drugs used by TB patients.
|Related News Press|
Nanoparticles simplify DNA identification and quantification November 27th, 2015
Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015
Electric fields remove nanoparticles from blood with ease November 24th, 2015
Production of Nanocapsules Containing Omega-3 Powder in Iran November 24th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
'Material universe' yields surprising new particle November 28th, 2015
RAMAN Spectrometry Makes Characterization of Various Nanostructures Possible November 28th, 2015
Nanoparticles Boost Impact Resistance of Special Type of Polymer November 28th, 2015
Omni Nano and Time Warner Cable Partner to Provide Nanotechnology Education to the Boys & Girls Clubs of Los Angeles: A $10,000 Donation to Benefit Youth of Los Angeles County's Boys & Girls Clubs August 4th, 2015
Kalam: versatility personified August 1st, 2015